PCR para diagnóstico de infecciones respiratorias Mercado: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00023326
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 284
Buy Now

El mercado de PCR para diagnóstico de infecciones respiratorias se valoró en 8.279,32 millones de dólares en 2028, frente a 4.146,02 millones de dólares en 2021; se estima que crecerá a una tasa compuesta anual del 10,4 % entre 2021 y 2028.

La reacción en cadena de la polimerasa (PCR) se utiliza para diagnósticos precisos en el punto de atención que ayudan a identificar rápidamente y determinar la causa de las infecciones del tracto respiratorio. Además, la PCR es ampliamente preferida en entornos hospitalarios y ambulatorios, lo que ayuda a mejorar el crecimiento del mercado en los últimos años.

El crecimiento del mercado de diagnóstico de infecciones respiratorias por PCR se atribuye a factores como la creciente carga de enfermedades respiratorias crónicas (CRD), el creciente desarrollo de las pruebas de PCR, están mejorando ampliamente el rendimiento de los dispositivos médicos. Sin embargo, el uso de pruebas de PCR para diversos diagnósticos de infecciones respiratorias y los avances en la tecnología de PCR se utilizan para derivarlos. La disponibilidad de ensayos alternativos obstaculiza el crecimiento del mercado.

regiones lucrativas para el mercado de PCR para diagnóstico de infecciones respiratorias


Perspectivas del mercado

Estrategias de consolidación del mercado adoptadas mediante el uso de pruebas de PCR para diversos diagnósticos de infecciones respiratorias

Las pruebas de PCR son el estándar de oro para detectar enfermedades infecciosas respiratorias, incluido el SARS-CoV-2. Además, los crecientes avances en PCR no se limitan a las pruebas de COVID-19. Los continuos avances tecnológicos han permitido a los investigadores desarrollar técnicas de PCR avanzadas a un coste reducido y limitar sus complejidades. Se espera que las pruebas de PCR mejoren sus capacidades para el diagnóstico molecular y fortalezcan su papel en el futuro con los desarrollos continuos de tecnologías como los microfluidos y la secuenciación de próxima generación. Además, las pruebas de PCR se utilizan significativamente en instituciones como hogares de ancianos, centros de atención crónica y hospitales, para identificar la infección por el virus de la influenza que causa brotes respiratorios.

Además, aguda y crónica Las infecciones respiratorias se encuentran entre las principales causas de morbilidad en los países desarrollados y en desarrollo a nivel mundial. Se estima que las enfermedades respiratorias agudas representan casi el 75% del total de morbilidades agudas a nivel mundial. Por ello, diversas empresas están ofreciendo diversos kits de PCR que pueden detectar la presencia de patógenos que causan enfermedades respiratorias. Por ejemplo, empresas como bioMérieux SA y altona Diagnostics GmbH ofrecen una amplia gama de kits de PCR que pueden detectar infecciones respiratorias agudas en el tracto respiratorio superior o inferior. Además de la creciente incidencia de enfermedades respiratorias agudas y crónicas, es probable que otros factores, como las condiciones ambientales y climáticas, la contaminación del aire y los descubrimientos de nuevas bacterias, virus y patógenos, sirvan como oportunidades de crecimiento vitales para las pruebas de PCR para el diagnóstico de infecciones respiratorias en el futuro próximo.

Información basada en tipos

El mercado de PCR para diagnóstico de infecciones respiratorias, por tipo, se segmenta en PCR en tiempo real (qPCR ), PCR multiplex, PCR tradicional, PCR digital, transcriptasa inversa (RT-PCR) y otras. El segmento de PCR en tiempo real (qPCR) tuvo la mayor participación del mercado en 2021 y se prevé que registre la CAGR más alta del mercado durante el período de pronóstico.

PCR para enfermedades respiratorias Mercado de diagnóstico de infecciones, por tipo: 2021 y 2028


Información basada en el tipo de producto

Según el tipo de producto, la PCR para infección respiratoria El mercado de diagnóstico se segmenta en reactivos y kits, instrumentos y otros. El segmento de reactivos y kits tuvo la mayor participación del mercado en 2021 y se prevé que registre la CAGR más alta del mercado durante el período de pronóstico.

Información basada en el tipo de infección

Según el tipo de infección, el mercado de diagnóstico de infecciones respiratorias por PCR se segmenta en infección bacteriana, infección viral y hongos y otros patógenos. En 2021, el segmento de infecciones virales tuvo la mayor participación del mercado y se estima que registrará la CAGR más alta del mercado durante el período de pronóstico.

Información basada en los usuarios finales

Basado en el usuario final, el mercado de PCR para diagnóstico de infecciones respiratorias se segmenta en hospitales, clínicas médicas y laboratorios clínicos. , instituciones académicas y de investigación, empresas biotecnológicas y farmacéuticas, y otros. En 2020, el segmento de laboratorios clínicos tuvo la mayor participación del mercado y se estima que registrará la CAGR más alta del mercado durante el período de pronóstico.

Perspectivas estratégicas

Los lanzamientos y aprobaciones de productos son las estrategias comúnmente adoptadas por las empresas para expandir su presencia global y sus carteras de productos. Además, los actores del mercado de la reconstrucción mamaria se centran en la estrategia de colaboración para ampliar su clientela, lo que, a su vez, les permite mantener su marca a nivel mundial.

Por tipo

  • PCR en tiempo real (qPCR)
  • PCR múltiple
  • PCR tradicional
  • PCR digital
  • Transcriptasa inversa (RT-PCR)< /li>
  • Otros

Por tipo de producto

  • Reactivos y kits
  • Instrumentos
  • Otros

Por tipo de infección

  • Infecciones bacterianas
    • Bordetella
    • Streptococcus pneumoniae
    • Estafilococo Aureus
    • Haemophilus Influenzae
    • Moraxella Catarrhalis
    • Mycoplasma Pneumoniae
    • Chlamydophila Pneumoniae
    • Legionella
    • < li>Otros
  • Infecciones virales
    • Rinovirus
    • Virus de la influenza
    • Síndrome respiratorio agudo severo (SARS) Virus CoV-2
    • Virus respiratorio sincitial (VRS)
    • Adenovirus
    • Enterovirus
    • Parainfluenza
    • Metapneumovirus humano (hMPV)
    • Otros
  • Hongos y otros patógenos

Por usuario final

  • Hospitales
  • Clínicas médicas
  • Laboratorios clínicos
  • Instituciones académicas y de investigación
  • Empresas de biotecnología y farmacéuticas
  • < li>Otros

Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • Europa
    • Francia
    • Alemania
    • Reino Unido
    • España
    • Países Bajos
    • Noruega
    • Italia
    • Resto de Europa
  • Asia Pacífico ( APAC)
    • China
    • India
    • Japón
    • Australia
    • Corea del Sur
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)
    • Arabia Saudita
    • EAU
    • Sudáfrica
    • Resto de Medio Oriente y África
  • América del Sur y Central (SCAM)
    • Brasil
    • Argentina
    • Resto de América del Sur y Central

Perfiles de empresas

  • Abbott
  • < li>F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Seegene Inc.
  • AusDiagnostics
  • BD
  • Bio -Rad Laboratories Inc
  • BioMérieux
  • Qiagen
  • Thermo Fisher Scientific Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is PCR test mean?

The polymerase chain reaction (PCR) is a simple and low-cost method for amplifying small portions of DNA. Because significant amounts of a sample of DNA are necessary for molecular and genetic analyze, studies of isolated fragments of DNA are almost impossible without PCR amplification.

What are the driving factors for the PCR for respiratory infection diagnostics market across the globe?

The growth of the market is attributed to some key driving factors such as as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth. In January 2020, Roche received CE Mark approval for an adenovirus test for transplant patients. It is intended to be used in conjunction with other infectious diseases tests available on their cobas systems (6800 and 8800). The majority of companies are now offering real-time polymerase chain reaction (PCR) tests for corona virus, which is contributing to the growth of the target market.Such strategic steps are also projected to drive the market growth.

What is the regional analysis in terms of PCR for respiratory infection diagnostics?

The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices. Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the Europe is expected account for the fastest growth in the PCR for respiratory infection diagnostics market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices growth of Europe PCR for respiratory infection diagnostics market during the forecast period.

The List of Companies - PCR for Respiratory Infection Diagnostic Market

  1. Abbott
  2. F. Hoffmann-La Roche AG
  3. Hologic, Inc.
  4. Seegene Inc.
  5. AusDiagnostics
  6. BD
  7. Bio-Rad Laboratories Inc
  8. BioMérieux
  9. Qiagen
  10. Thermo Fisher Scientific Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports